25 found
Order:
Disambiguations
Luke Gelinas [24]Luke C. Gelinas [1]
See also
Luke Gelinas
Albany Medical College
  1.  18
    IRBs and the Protection-Inclusion Dilemma: Finding a Balance.Phoebe Friesen, Luke Gelinas, Aaron Kirby, David H. Strauss & Barbara E. Bierer - 2022 - American Journal of Bioethics 23 (6):75-88.
    Institutional review boards, tasked with facilitating ethical research, are often pulled in competing directions. In what we call the protection-inclusion dilemma, we acknowledge the tensions IRBs face in aiming to both protect potential research participants from harm and include under-represented populations in research. In this manuscript, we examine the history of protectionism that has dominated research ethics oversight in the United States, as well as two responses to such protectionism: inclusion initiatives and critiques of the term vulnerability. We look at (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   20 citations  
  2.  59
    Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations.Luke Gelinas, Robin Pierce, Sabune Winkler, I. Glenn Cohen, Holly Fernandez Lynch & Barbara E. Bierer - 2017 - American Journal of Bioethics 17 (3):3-14.
    The use of social media as a recruitment tool for research with humans is increasing, and likely to continue to grow. Despite this, to date there has been no specific regulatory guidance and there has been little in the bioethics literature to guide investigators and institutional review boards faced with navigating the ethical issues such use raises. We begin to fill this gap by first defending a nonexceptionalist methodology for assessing social media recruitment; second, examining respect for privacy and investigator (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   22 citations  
  3.  19
    When clinical trials compete: prioritising study recruitment.Luke Gelinas, Holly Fernandez Lynch, Barbara E. Bierer & I. Glenn Cohen - 2017 - Journal of Medical Ethics 43 (12):803-809.
    It is not uncommon for multiple clinical trials at the same institution to recruit concurrently from the same patient population. When the relevant pool of patients is limited, as it often is, trials essentially compete for participants. There is evidence that such a competition is a predictor of low study accrual, with increased competition tied to increased recruitment shortfalls. But there is no consensus on what steps, if any, institutions should take to approach this issue. In this article, we argue (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   12 citations  
  4.  57
    When and Why Is Research without Consent Permissible?Luke Gelinas, Alan Wertheimer & Franklin G. Miller - 2016 - Hastings Center Report 46 (2):35-43.
    The view that research with competent adults requires valid consent to be ethical perhaps finds its clearest expression in the Nuremberg Code, whose famous first principle asserts that “the voluntary consent of the human subject is absolutely essential.” In a similar vein, the United Nations International Covenant on Civil and Political Rights states that “no one shall be subjected without his free consent to medical or scientific experimentation.” Yet although some formulations of the consent principle allow no exceptions, others hold (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   12 citations  
  5.  6
    Institutional Review Board Use of Outside Experts: A National Survey.Kimberley Serpico, Vasiliki Rahimzadeh, Luke Gelinas, Lauren Hartsmith, Holly Fernandez Lynch & Emily E. Anderson - 2022 - AJOB Empirical Bioethics 13 (4):251-262.
    Background Institutional review board (IRB) expertise is necessarily limited by maintaining a manageable board size. IRBs are therefore permitted by regulation to rely on outside experts for review. However, little is known about whether, when, why, and how IRBs use outside experts.Methods We conducted a national survey of U.S. IRBs to characterize utilization of outside experts. Our study uses a descriptive, cross-sectional design to understand how IRBs engage with such experts and to identify areas where outside expertise is most frequently (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  6.  51
    Nudging, Autonomy, and Valid Consent: Context Matters.Franklin G. Miller & Luke Gelinas - 2013 - American Journal of Bioethics 13 (6):12-13.
  7. The problem of natural evil I: General theistic replies.Luke Gelinas - 2009 - Philosophy Compass 4 (3):533-559.
    I examine different strategies involved in stating anti-theistic arguments from natural evil, and consider some theistic replies. There are, traditionally, two main types of arguments from natural evil: those that purport to deduce a contradiction between the existence of natural evil and the existence of God, and those that claim that the existence of certain types or quantities of natural evil significantly lowers the probability that theism is true. After considering peripheral replies, I state four prominent theistic rebutting strategies: skeptical (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  8.  26
    Rights, Nudging, and the Good of Others.Luke Gelinas - 2016 - American Journal of Bioethics 16 (11):17-19.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  9.  16
    COVID-19 and consent for research: Navigating during a global pandemic.Ran D. Goldman & Luke Gelinas - 2021 - Clinical Ethics 16 (3):222-227.
    The modern ethical framework demands informed consent for research participation that includes disclosure of material information, as well as alternatives. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic (COVID-19) results in illness that often involves rapid deterioration. Despite the urgent need to find therapy, obtaining informed consent for COVID-19 research is needed. The current pandemic presents three types of challenges for investigators faced with obtaining informed consent for research participation: (1) uncertainty over key information to informed consent, (2) time (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  10.  12
    Allocation of Opportunities to Participate in Clinical Trials during the Covid‐19 Pandemic and Other Public Health Emergencies.Kayte Spector-Bagdady, Holly Fernandez Lynch, Barbara E. Bierer, Luke Gelinas, Sara Chandros Hull, David Magnus, Michelle N. Meyer, Richard R. Sharp, Jeremy Sugarman, Benjamin S. Wilfond, Ruqaiijah Yearby & Seema Mohapatra - 2021 - Hastings Center Report 52 (1):51-58.
    Hastings Center Report, Volume 52, Issue 1, Page 51-58, January/February 2022.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  11. The problem of natural evil II: Hybrid replies.Luke Gelinas - 2009 - Philosophy Compass 4 (3):560-574.
    I consider two views that combine different elements of general theistic replies to natural evil, those of Peter van Inwagen and William Hasker. I end with a Hasker-style defense – one that, unlike Hasker's, denies the existence of pointless natural evils – and some brief observations on the direction of future debate.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  12.  2
    On measuring attitudes about payment for research.Luke Gelinas - 2020 - Journal of Medical Ethics 46 (12):833-834.
    Significant attention has been given both to the ethics of Controlled Human Infection Model research and the ethics of payment for research participation. However, comparatively little attention has been given to the ethics of paying for participation specifically in CHIM research. Grimwade et al should be commended for thoughtfully addressing this topic and especially for the empirical data collection informing their work, which is too often lacking in discussions of payment for research participation. In what follows I will discuss three (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  13.  6
    The Decision to Enroll in a Clinical Trial Should Be Unencumbered.Luke Gelinas & Barbara E. Bierer - 2020 - American Journal of Bioethics 20 (9):23-25.
    Volume 20, Issue 9, September 2020, Page 23-25.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  14.  20
    On Scarcity and the Value of Clinical Trials.Luke Gelinas, Holly Fernandez Lynch, Barbara E. Bierer & I. Glenn Cohen - 2018 - American Journal of Bioethics 18 (4):71-73.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  15.  24
    Institutions as an ethical locus of research prioritisation.Luke Gelinas, Holly Fernandez Lynch, Barbara Bierer & I. Glenn Cohen - 2017 - Journal of Medical Ethics 43 (12):816-818.
    Ensuring that clinical trials, once launched, successfully complete and generate useful knowledge is an important and indeed ethically imperative goal, given the risks and burdens borne by research participants. Since there are insufficient willing research participants to power all the trials that are currently undertaken,1 addressing underenrolment will require prioritisation decisions that reduce the number of trials competing for participants. While there are multiple levels at which research priority-setting can and does take place, competition between trials often plays out in (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  16.  16
    Nonexceptionalism, Research Risks, and Social Media: Response to Open Peer Commentaries on “Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations”.Luke Gelinas, Robin Pierce, Sabune Winkler, Glenn Cohen, Holly Fernandez Lynch & Barbara E. Bierer - 2017 - American Journal of Bioethics 17 (5):1-3.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  17.  10
    Acknowledging Complexity and Reimagining IRBs: A Reply to Discussions of the Protection–Inclusion Dilemma.Phoebe Friesen, Luke Gelinas, Aaron Kirby, David H. Strauss & Barbara E. Bierer - 2023 - American Journal of Bioethics 23 (9):1-8.
    We are grateful to everyone who took the time to offer such insightful comments with regard to the protection–inclusion dilemma in research oversight. Nearly all respondents agreed that this dilemm...
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  18.  49
    Frames, Choice-Reversal, and Consent.Luke Gelinas - 2015 - Ethical Theory and Moral Practice 18 (5):1049-1057.
    Recently Jason Hanna has argued that a particular type of susceptibility to framing effects—namely, the tendency to reverse one’s choice between certain logically equivalent frames—invalidates actual tokens of consent. Here I argue that this claim is false: proneness to choice-reversal per se between the relevant types of frames does not invalidate consent.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  19.  13
    Social Media as an Ethical Tool for Retention in Clinical Trials.Luke Gelinas & Barbara E. Bierer - 2019 - American Journal of Bioethics 19 (6):62-64.
    Volume 19, Issue 6, June 2019, Page 62-64.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  20.  52
    The Stoic Argument Ex Gradibus Entium.Luke Gelinas - 2006 - Phronesis 51 (1):49 - 73.
    In this paper I offer an interpretation of the Stoic argumentum ex gradibus entium as it appears in Book II of Cicero's De Natura Deorum. In addition to displaying certain similarities to later formulations of the so-called "ontological argument," particularly Anselm's, I argue that the argument ex gradibus entium was a versatile feature of Stoic philosophical theology, capable of employment in relation to two distinct topics: the existence of god and the identification of god's essential nature with the world. I (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  21.  18
    Mutual Obligations in Research and Withholding Payment From Deceptive Participants.Holly Fernandez Lynch, Luke Gelinas & Emily A. Largent - 2018 - American Journal of Bioethics 18 (4):85-87.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  22.  5
    Ensuring the Scientific Value and Feasibility of Clinical Trials: A Qualitative Interview Study.Walker Morrell, Luke Gelinas, Deborah Zarin & Barbara E. Bierer - 2023 - AJOB Empirical Bioethics 14 (2):99-110.
    Background Ethical and scientific principles require that clinical trials address an important question and have the resources needed to complete the study. However, there are no clear standards for review that would ensure that these principles are upheld.Methods We conducted semi-structured interviews with a convenience sample of nineteen experts in clinical trial design, conduct, and/or oversight to elucidate current practice and identify areas of need with respect to ensuring the scientific value and feasibility of clinical trials prior to initiation and (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  23.  34
    In Particular Circumstances Attempting Unproven Interventions Is Permissible and Even Obligatory.Bruce D. White, Luke C. Gelinas & Wayne N. Shelton - 2015 - American Journal of Bioethics 15 (4):53-55.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  24. God, the Best, and Evil. [REVIEW]Klaas J. Kraay & Luke Gelinas - 2010 - Philosophical Quarterly 60 (239):432-446.
  25.  11
    For the common good: Philosophical foundations of research ethics. London, Alex John. New York, NY: Oxford University Press, 2022. 453 pp. ISBN 9780197534830. $99.00. (Hardback) Open Access free PDF download at Oxford Scholarship Online. [REVIEW]Luke Gelinas - 2023 - Bioethics 37 (6):610-612.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark